| 1 |
34756920 | Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells. | 2022 Feb |
1 |
| 2 |
34983657 | Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro. | 2022 Jan 4 |
1 |
| 3 |
34995983 | 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1. | 2022 Feb 5 |
1 |
| 4 |
33070154 | The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study. | 2021 Apr |
2 |
| 5 |
33607363 | Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies. | 2021 Apr |
4 |
| 6 |
33723207 | Fear extinction learning and anandamide: an fMRI study in healthy humans. | 2021 Mar 15 |
3 |
| 7 |
33834617 | Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase. | 2021 Jul 20 |
2 |
| 8 |
34217798 | The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease? | 2021 Sep |
2 |
| 9 |
34893921 | FAAH polymorphism (rs324420) modulates extinction recall in healthy humans: an fMRI study. | 2021 Dec 10 |
3 |
| 10 |
32041998 | The endocannabinoid hydrolase FAAH is an allosteric enzyme. | 2020 Feb 10 |
3 |
| 11 |
32292082 | Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? | 2020 Jul |
4 |
| 12 |
32681461 | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects. | 2020 Sep |
1 |
| 13 |
33374180 | In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors. | 2020 Dec 24 |
2 |
| 14 |
30532004 | Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. | 2019 Jul |
2 |
| 15 |
30739035 | Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. | 2019 Apr |
2 |
| 16 |
30822695 | Posttreatment With the Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates One-Lung Ventilation-Induced Lung Injury in a Rabbit Model. | 2019 Jul |
1 |
| 17 |
30842391 | New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System. | 2019 Mar 7 |
2 |
| 18 |
31117309 | Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands. | 2019 May 21 |
1 |
| 19 |
30114402 | Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. | 2018 Oct |
1 |
| 20 |
30126012 | FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. | 2018 Oct |
1 |
| 21 |
27000802 | Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes. | 2016 Jun |
2 |
| 22 |
27516570 | Metabolism of endocannabinoids. | 2016 Aug 11 |
1 |
| 23 |
27790143 | A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs). | 2016 |
1 |
| 24 |
25519724 | A simple method for simultaneous determination of N-arachidonoylethanolamine, N-oleoylethanolamine, N-palmitoylethanolamine and 2-arachidonoylglycerol in human cells. | 2015 Feb |
1 |
| 25 |
25975960 | Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. | 2015 Jul |
1 |
| 26 |
23347118 | Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. | 2013 Oct |
4 |
| 27 |
23488865 | Latest advances in the discovery of fatty acid amide hydrolase inhibitors. | 2013 May |
2 |
| 28 |
21924613 | Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain. | 2011 Nov 1 |
2 |
| 29 |
20096328 | Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. | 2010 Apr |
2 |
| 30 |
17553686 | Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes. | 2007 Jul |
2 |
| 31 |
17901541 | Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. | 2007 Sep |
3 |
| 32 |
16375688 | Partial QSAR analysis of some selected natural inhibitors of FAAH suggests a working hypothesis for the development of endocannabinoid-based drugs. | 2005 Dec |
2 |
| 33 |
11585048 | Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. | 2001 Sep 1 |
1 |
| 34 |
10820223 | Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. | 2000 Jun |
1 |